-
4
-
-
17944376779
-
-
Heerding D.A., Chan G., DeWolf W.E., Fosberry A.P., Janson C.A., Jaworski D.D., McManus E., Miller W.H., Moore T.D., Payne D.J., Qiu X., Rittenhouse S.F., Slater-Radosti C., Smith W., Takata D.T., Vaidya K.S., Yuan C.C.K., and Huffman W.F. Bioorg. Med. Chem. Lett. 11 (2001) 2061
-
(2001)
Bioorg. Med. Chem. Lett.
, vol.11
, pp. 2061
-
-
Heerding, D.A.1
Chan, G.2
DeWolf, W.E.3
Fosberry, A.P.4
Janson, C.A.5
Jaworski, D.D.6
McManus, E.7
Miller, W.H.8
Moore, T.D.9
Payne, D.J.10
Qiu, X.11
Rittenhouse, S.F.12
Slater-Radosti, C.13
Smith, W.14
Takata, D.T.15
Vaidya, K.S.16
Yuan, C.C.K.17
Huffman, W.F.18
-
5
-
-
0037130227
-
-
Miller W.H., Seefeld M.A., Newlander K.A., Uzinskas I.N., Burgess W.J., Heerding D.A., Yuan C.C.K., Head M.S., Payne D.J., Rittenhouse S.F., Moore T.D., Pearson S.C., Berry V., DeWolf W.E., Polizzi B.J., Qiu X., and Janson C.A. J. Med. Chem. 45 (2002) 3246
-
(2002)
J. Med. Chem.
, vol.45
, pp. 3246
-
-
Miller, W.H.1
Seefeld, M.A.2
Newlander, K.A.3
Uzinskas, I.N.4
Burgess, W.J.5
Heerding, D.A.6
Yuan, C.C.K.7
Head, M.S.8
Payne, D.J.9
Rittenhouse, S.F.10
Moore, T.D.11
Pearson, S.C.12
Berry, V.13
DeWolf, W.E.14
Polizzi, B.J.15
Qiu, X.16
Janson, C.A.17
-
6
-
-
0037464456
-
-
Seefeld M.A., Miller W.H., Newlander K.A., Burgess W.J., DeWolf W.E., Elkins P.A., Head M.S., Jakas D.R., Janson C.A., Keller P.M., Manley P.J., Heerding D.A., Chan G., Fosberry A.P., Jaworski D.D., Moore T.D., Payne D.J., Pearson S., Polizzi B.J., Qiu X., Rittenhouse S.F., Uzinskas I.N., Wallis N.G., and Huffman W.F. J. Med. Chem. 46 (2003) 1627
-
(2003)
J. Med. Chem.
, vol.46
, pp. 1627
-
-
Seefeld, M.A.1
Miller, W.H.2
Newlander, K.A.3
Burgess, W.J.4
DeWolf, W.E.5
Elkins, P.A.6
Head, M.S.7
Jakas, D.R.8
Janson, C.A.9
Keller, P.M.10
Manley, P.J.11
Heerding, D.A.12
Chan, G.13
Fosberry, A.P.14
Jaworski, D.D.15
Moore, T.D.16
Payne, D.J.17
Pearson, S.18
Polizzi, B.J.19
Qiu, X.20
Rittenhouse, S.F.21
Uzinskas, I.N.22
Wallis, N.G.23
Huffman, W.F.24
more..
-
9
-
-
61949263942
-
-
Brinster S., Lamberet G., Stael B., Trieu-Cuot P., Gruss A., and Poyart C. Nature 458 (2009) 83
-
(2009)
Nature
, vol.458
, pp. 83
-
-
Brinster, S.1
Lamberet, G.2
Stael, B.3
Trieu-Cuot, P.4
Gruss, A.5
Poyart, C.6
-
10
-
-
68949151475
-
-
note
-
The coordinates were obtained from the PBD under the accession code 1MFP.
-
-
-
-
11
-
-
68949148458
-
-
Berman, J; Sampson, P.; Pauls, H.W.; Ramnauth, J.; Manning, D.; Surman, M.D.; Xie, D.; Decornez, H.Y.; Pct. Intl. Appl. WO 2004052890, 2004.
-
Berman, J; Sampson, P.; Pauls, H.W.; Ramnauth, J.; Manning, D.; Surman, M.D.; Xie, D.; Decornez, H.Y.; Pct. Intl. Appl. WO 2004052890, 2004.
-
-
-
-
12
-
-
68949101137
-
-
Clarke, T.; Buzadzja, K.; Dorsey, M.; Abstract of papers, 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, October, 2004; Abstract F-1527.
-
Clarke, T.; Buzadzja, K.; Dorsey, M.; Abstract of papers, 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, October, 2004; Abstract F-1527.
-
-
-
-
14
-
-
68949100128
-
-
note
-
S. aureus FabI inhibition assays were carried out as described in Ref. 5, using a FabI enzyme concentration of 3 nM. E. coli FabI inhibition assays were carried out in half area 96 well plates containing 150 μL of 100 mM MOPS pH 7.2, 50 mM ammonium acetate, 3% glycerol, 25 μM crotonyl-ACP, 50 μM NADH, and 0.5 nM enzyme. Consumption of NAD(P)H was monitored at 340 nm and a titration of standard compound was included on each dose response plate as a positive control.
-
-
-
-
15
-
-
68949150463
-
-
note
-
MIC testing was performed on bacterial strains from the Affinium bacterial collection or the American Type Culture Collection (Manassas, VA) according to CLSI guidelines using the microdilution method in 96 wellplates: National Committee for Clinical Laboratory Standards 2003. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, Fifth Ed., Approved Standard M7-A6. NCCLS, Wayne, PA, USA.
-
-
-
|